As of 2025-07-22, the Intrinsic Value of Kimia Farma Tbk PT (KAEF.JK) is (2,125.03) IDR. This KAEF.JK valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 560.00 IDR, the upside of Kimia Farma Tbk PT is -479.50%.
The range of the Intrinsic Value is (3,552.24) - (1,772.53) IDR
Based on its market price of 560.00 IDR and our intrinsic valuation, Kimia Farma Tbk PT (KAEF.JK) is overvalued by 479.50%.
Note: result may not be accurate due to the invalid valuation result of DCF model.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | (3,552.24) - (1,772.53) | (2,125.03) | -479.5% |
DCF (Growth 10y) | (1,021.19) - (128.88) | (847.54) | -251.3% |
DCF (EBITDA 5y) | (1,018.41) - (822.24) | (1,234.50) | -123450.0% |
DCF (EBITDA 10y) | (735.57) - (227.90) | (1,234.50) | -123450.0% |
Fair Value | -6,273.32 - -6,273.32 | -6,273.32 | -1,220.24% |
P/E | (3,648.57) - (3,492.99) | (3,657.35) | -753.1% |
EV/EBITDA | (2,302.85) - (2,545.15) | (2,440.52) | -535.8% |
EPV | (1,423.46) - (1,593.05) | (1,508.26) | -369.3% |
DDM - Stable | (1,326.19) - (2,613.98) | (1,970.08) | -451.8% |
DDM - Multi | (569.74) - (868.44) | (687.64) | -222.8% |
Market Cap (mil) | 3,860,858.50 |
Beta | 1.30 |
Outstanding shares (mil) | 6,894.39 |
Enterprise Value (mil) | 10,929,358.00 |
Market risk premium | 7.88% |
Cost of Equity | 14.94% |
Cost of Debt | 5.91% |
WACC | 7.97% |